Bipartisan Advancement Of Key Drug Pricing Bills Signals A Coming Victory For American Patients

04-4-2019 Press Release

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement after the U.S. House Energy & Commerce Committee advanced a series of bipartisan drug pricing measures, including the CREATES Act, Purple Book Continuity Act of 2019, Orange Book Transparency Act of 2019 and Protecting Consumer Access to Generic Drugs Act of […]

THEY SAID IT! Lawmakers Blast Insulin Price Hikes, Call For Drug Price Action And Question The Rebate Rule

04-3-2019 Press Release

On Tuesday, the U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations held a hearing to discuss with expert witnesses the “Human Impact Of Rising Insulin Costs.”  Members of the subcommittee shared harrowing stories of constituents or loved ones suffering from rising insulin prices and many members expressed their eagerness to address […]

CSRxP Encourages House Lawmakers To Advance Bipartisan Drug Pricing Legislation

04-2-2019 Press Release

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a bill markup in the U.S. House Committee on Energy and Commerce on a number of bipartisan drug pricing measures: “We applaud committee leaders in Congress who continue to focus on meaningfully addressing the crisis of rising prescription drug […]

Insulin Hearing Will Add To Drug Pricing Momentum On Capitol Hill 

04-1-2019 Press Release

CSRxP Commends House Energy & Commerce Committee For Giving Voice To Patients Struggling To Afford Their Medication Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today ahead of a U.S. House  Committee on Energy and Commerce Subcommittee on Oversight and Investigations hearing Tuesday on rising insulin prices: “We commend Subcommittee […]

They Said It! Lawmakers Advance Key Drug Pricing Bills

03-28-2019 Press Release

House Energy & Commerce Members Recommit To Bipartisan Action As Critical Measures Advance On Wednesday, the U.S. House Committee on Energy & Commerce Subcommittee on Health approved several key pieces of legislation aiming to bring down drug prices through increased competition and transparency.  This development marks positive progress, but much more needs to be done […]

CSRxP Applauds House Lawmakers For Keeping Momentum Going On Key Drug Price Legislation

03-27-2019 Press Release

U.S. House Committee On Energy & Commerce Health Subcommittee Will Markup Several Prescription Drug Bills Wednesday Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a bill markup in the U.S. House Committee on Energy & Commerce Subcommittee on Health on a number of crucial, bipartisan drug pricing […]

ICYMI: Drug Prices Are A Matter Of Life And Death

03-21-2019 Press Release

The Hill Lauren Aronson March 21, 2019 https://thehill.com/blogs/congress-blog/435132-drug-prices-are-a-matter-of-life-and-death Few issues are more pressing today than out-of-control drug prices. One in four Americans are unable to afford their medications, and many of them are rationing — or altogether giving up — the very treatments they need to live, sometimes with fatal consequences. As Kathy Sego — […]

CSRxP: Legislative Hearing on Drug Pricing Bills a Positive First Step, Now More Action Needed

03-13-2019 Press Release

Today, members of the U.S. House Committee on Energy & Commerce Subcommittee on Health held a legislative hearing on a number of proposals to tackle skyrocketing drug prices, more evidence of building momentum in Congress to take concrete action. “Today’s hearing was an important first step toward passing bipartisan, market-based solutions like the CREATES Act […]

Questioning The Rebate Rule

03-12-2019 Press Release

Secretary Azar Recently Noted The Effectiveness Of PBMs Now Targeted By Agency Proposal U.S. Department of Health and Human Services (HHS) Secretary Alex Azar will head to Capitol Hill on Tuesday where he will testify on the Trump Administration’s budget proposal before the U.S. House Committee on Energy and Commerce Subcommittee on Health.  During his […]

Trump Administration Should Focus on Market-Based Solutions to Alleviate Drug Prices

03-11-2019 Press Release

As Secretary Azar Heads To Capitol Hill, CSRxP Encourages Lawmakers To Question Budget-Busting $200 Billion Rebate Rule Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of U.S. Department of Health and Human Services Secretary Alex Azar testifying Tuesday on the president’s budget and drug pricing before the U.S. […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.